AN2 Therapeutics Ratios (2021-2026) | ANTX

Ratios Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Efficiency
Assets Average (Quarter)
92.91M120.26M115.01M106.28M96.82M95.00M126.37M146.28M130.00M114.87M103.08M94.89M86.72M78.58M71.53M64.59M74.72M
Equity Average (Quarter)
-26.48M-34.10M-42.88M34.00M115.64M110.72M100.47M88.94M85.14M113.37M131.84M117.65M104.48M93.01M84.76M77.59M71.09M64.61M56.72M67.41M
Invested Capital (Quarter)
-29.84M-38.35M-47.41M115.41M115.86M105.57M95.37M82.52M87.76M138.97M124.70M110.60M98.35M87.67M81.85M73.33M68.84M60.38M53.06M81.76M
Leverage & Solvency
Equity Ratio (Quarter)
-0.730.960.970.960.930.910.890.900.900.910.910.900.890.900.910.900.860.93
Valuation
Enterprise Value (Quarter)
-58.56M-118.35M-113.37M-104.38M-96.06M-88.52M-95.25M-123.82M-107.25M-114.21M-104.54M-93.43M-83.62M-67.08M-62.92M-61.92M-57.96M-85.30M
Return Ratios
Return on Capital Employed (Quarter)
-30.98%-28.03%-33.80%-42.65%-57.35%-67.85%-56.75%-52.66%-72.00%-67.09%-68.21%-53.68%
Return on Assets (Quarter)
0.00%0.00%0.00%0.00%-0.01%-0.01%0.00%0.00%-0.01%-0.01%-0.01%-0.01%-0.01%0.00%0.00%-0.01%0.00%
Return on Equity (Quarter)
0.01%-0.01%0.00%0.00%0.00%-0.01%-0.01%-0.01%-0.01%-0.01%-0.01%-0.01%-0.01%-0.01%-0.01%-0.01%-0.01%-0.01%